Sildenafil and Pharma: A Precarious Opportunity?

The history of the erectile dysfunction drug presents a complex picture for shareholders. While the initial launch generated significant profits, the end of its patent opened the avenue to generic competitors, dramatically eroding market share. This presents a specific challenge for get more info drug manufacturers relying on similar blockbuster pr

read more

Sildenafil and the Pharmaceutical Sector : A Precarious Investment ?

The story of Viagra, and its creator copyright, presents a complex case study for investors. Originally a blockbuster drug, producing billions in revenue , its patent expiration created a deluge of lower-priced alternatives , significantly diminishing its market share . While specific businesses may try to capitalize on similar conditions , the exi

read more